News – Page 495 – Endpoints News

SIGN UP

Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma

3 years ago

As court case looms, Bristol Myers touts label expansion for Breyanzi

3 years ago

State battles over mifepristone access could tie the FDA to any post-Roe crossroads

3 years ago

After a 5-year repeat PhIII sojourn, Lundbeck and Otsuka say they're finally ready to pursue OK to use Rexulti ...

3 years ago

A Merck partner is sucked into the financial quagmire as key lender calls in a note

3 years ago

Biden and G7 nations offer funds for vaccine and medical product manufacturing project in Senegal

3 years ago

Federal judge denies Bristol Myers' attempt to avoid Celgene shareholder lawsuit

3 years ago

Takeda, Arrowhead spotlight data from small trial showing RNAi works in a rare liver condition

3 years ago

Mitochondria biotech receives Morningside buyout offer after PhII fail; Oncology microcap withdraws IPO plans

3 years ago

Capricor hits primary endpoint in Duchenne extension study, readying its FDA pitch

3 years ago

FDA places partial clinical hold on David Hung biotech after certain cancer patients experience eye inflammation

3 years ago

Battle-tested biotech execs turn to an experienced industry godfather for some boardroom guidance

3 years ago

Relay builds out case for anti-FGFR drug, shooting for first accelerated approval on 'motion-based' drug discovery ...

3 years ago

No stranger to gene therapy woes, Astellas runs into another safety-related clinical hold

3 years ago

Updating the Covid-19 vaccine: FDA offers a qualified thumbs-up ahead of adcomm

3 years ago

Scoop: Boehringer quietly shutters a PhII for one of its top drugs — now under review

3 years ago

Ipsen snags an approved cancer drug in $247M M&A deal as another battered biotech sells cheap

3 years ago

GSK says its drug for chronic hep B could ‘lead to a functional cure’ — but will it be alone or in combination?

3 years ago

15 LGBTQ leaders in biopharma; Paul Stoffels’ Galapagos revamp; AstraZeneca catches up in ATTR; and more

3 years ago

Despite a slow start to the year for deals, PwC predicts a flurry of activity coming up

3 years ago

FDA unveils new draft guidance to help with oligonucleotide therapeutics development

3 years ago

Following SCOTUS decision to overturn abortion protections, AG Garland says states can't ban the abortion pill

3 years ago

Amryt Pharma submits a formal dispute resolution to the FDA over rejected skin disease drug

3 years ago

VC firms take osteoporosis drugmaker Radius Health private for almost $900M

3 years ago

First page Previous page 492 493 494495496 497 498 Next page Last page